CMS/NCI Will Test Model For Evidence-Based Reimbursement

A collaboration between the National Cancer Institute and the Centers for Medicare & Medicaid Services will examine cancer therapies as a model for evidence-based reimbursement, NCI Director Andrew von Eschenbach, MD, told the Milken Institute Global Conference in Los Angeles April 26-27